Dear John,

Join us next Tuesday, July 23, for a Health Affairs Journal Club meeting with author Kathleen L. Miller discussing the US Food and Drug Administration’s breakthrough therapy designation (BTD) program.

This event is exclusive to our Health Affairs Insiders.

Become an Insider today to stay up-to-date on what health care experts are thinking and talking about.

Today's Featured Articles

From the Journal: FDA Breakthrough Therapy Designation Reduced Late-Stage Drug Development Time

Kathleen L. Miller et al.

Forefront: Protecting Federally Qualified Health Centers Amid Drugstore Closures And Threats To 340B

Callie A. Gu et al.

Forefront: Nursing Home Trade Associations Challenge Administration’s New Staffing Requirements

Sheela Ranganathan

More on Pharmaceuticals

• Confronting High Costs And Clinical Uncertainty: Innovative Payment Models For Gene Therapies by Caroline Horrow and Aaron S. Kesselheim
  
  
• Characteristics Of Key Patents Covering Recent FDA-Approved Drugs by Victor L. Van de Wiele et al.
  
  
• A Health Podyssey: Mariana Socal on the Global Supply Chain for Generic Drugs

The Chevron Deference is Dead. What Now? w/ Andrew Twinamatsiko

Health Affairs' Jeff Byers welcomes Andrew Twinamatsiko of the O'Neill Institute for National and Global Health Law back to the program to discuss the Supreme Court's recent overturning of the Chevron doctrine and the implications for health policy moving forward.

Health Affairs Scholar is celebrating its one-year anniversary.

The digital journal published its first issue in July 2023 with a dedication to emerging policy trends and global health.

Its presence is growing. Cited by Congress and national media outlets like the New York Times, NPR, and the Los Angeles Times, Scholar has published papers on health care costs, access, quality, and equity. High-impact papers have included:

• Active steps to reduce administrative spending associated with financial transactions in US health care
• Food and Drug Administration novel drug decisions in 2017: transparency and disclosure prior to and 5 years following approval
• Has the fall of Roe changed contraceptive access and use? New research from four US states offers critical insights

Read about Scholar’s first year from Editor-in-Chief Kathryn Phillips on Forefront.